Sellers of At-Home Treatment for Opioid Withdrawal and Addiction Barred from Making Deceptive Claims

Defendants Also Required To Pay $235,000
The marketers of Elimidrol, a powdered drink mix touted as enabling opiate-addicted consumers to overcome addiction and withdrawal, have settled an FTC complaint that their claims were false and misleading

See the full post at FTC.gov